RecruitingNot ApplicableNCT06997419

Dexamethasone Palmitate for PONV After Open Surgery

Intravenous Dexamethasone Palmitate for Prophylaxis of Postoperative Nausea and Vomiting After Open Surgery

Sponsor

Beijing Tiantan Hospital

Enrollment

500 participants

Start Date

Jul 1, 2025

Study Type

INTERVENTIONAL

Conditions

Postoperative nausea and vomiting Open Surgery Dexamethasone Palmitate

Summary

Dexamethasone is almost one of the most commonly used drugs for postoperative nausea and vomiting (PONV) prevention. However, PONV is still a complex problem to be solved; for example, even with preoperative dexamethasone administration, there are still some patients still experience PONV within 24 hours postoperatively. Compared to dexamethasone, dexamethasone palmitate has a long-lasting anti-inflammatory effect, 2-5 times that of traditional water-soluble dexamethasone, with fewer adverse effects. This trial aims to assess the effect and safety of preoperative dexamethasone palmitate on PONV after open surgery.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

Aged 18 to 65 years;
Providing written informed consent;
Perform elective open surgery (Spinal surgery, open chest surgery, open abdominal surgery) undergoing general anesthesia.

Exclusion Criteria6

Known to be allergic to dexamethasone;
Any systemic glucocorticoids within 3 months before trial entry;
History of severe heart disease, liver/kidney failure, or systemic rheumatic diseases (rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, et al);
Cognitive impairment or severe mental illness;
Uncontrolled diabetes or infectious diseases;
Pregnancy or breastfeeding.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexamethasone Palmitate

Patients in the dexamethasone palmitate group will be assigned to receive intravenous injection of dexamethasone palmitate 8 mg (contains 5mg dexamethasone) after anesthesia induction and before surgical incision.

DRUGDexamethasone

Patients in the dexamethasone group will be assigned to receive intravenous injections of dexamethasone 5 mg after anesthesia induction and before surgical incision.